Intralesional epidermal growth factor application is a potential therapeutic strategy to improve diabetic foot ulcer healing and prevent amputation

Creative Commons License

ÇETİNKAYA Ö. A., Celik S. U., Erzincan M. B., HAZIR B., UNCU H.

TURKISH JOURNAL OF SURGERY, cilt.36, sa.1, ss.15-22, 2020 (ESCI) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 36 Sayı: 1
  • Basım Tarihi: 2020
  • Doi Numarası: 10.5578/turkjsurg.4541
  • Dergi Adı: TURKISH JOURNAL OF SURGERY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.15-22
  • Anahtar Kelimeler: Amputation, diabetic foot ulcer, epidermal growth factor, EFFICACY, SKIN, GUIDELINES, REPAIR, MOUSE, PHASE
  • Ankara Üniversitesi Adresli: Evet

Özet

Objective:This study aimed to investigate the efficacy of intralesional epidermal growth factor (EGF) in preventing the extremity from a major amputation and its effects on wound healing in chronic diabetic foot ulcers (DFUs).